A 13-year-old boy presented to our ophthalmology outpatient department with gradual loss of vision in both eyes for past 6 months and the best-corrected visual acuity in right eye was 6/12 and left eye was 6/18. Anterior segment examination was within normal limits. Fundus examination showed right eye partially absorbed egg yolk like lesions in macula and left eye macula shows yellowish scrambled egg like lesions. Electro-oculogram showed reduced Arden's ratio. Patient was diagnosed to have best disease and as best disease is a bilateral macular dystrophy with autosomal-dominant inheritance it can occur in family members and therefore his parents and siblings were called for ocular examination and were found to have the best disease. So genetic counselling and screening of family members should be carried out or the disease can be missed out.
INTRODUCTION
Genetic related ophthalmic problems are common, but usually all family members do not come for ocular examination and many genetic diseases are missed out in family members. Still genetic counselling of family members is poor in our country. This case suggests the importance of genetic counselling and motivation of family members for examination.
CASE REPORT
A 13-year-old boy presented to ophthalmology outpatient department with complaints of painless, gradual loss of vision in both eyes for 6 months duration. Examination showed that his visual acuity in right eye was 6/12 and left eye was 6/18 not improving with pinhole and the color vision was normal. Anterior segment examination was within normal limits. Pupils were reacting to both direct and indirect light reflex. Fundus examination of both eyes showed that the media was clear, disc and vessels were normal. Right eye macula shows partially absorbed egg yolk like lesions [ Figure 1 ] and left eye macula shows yellowish scrambled egg like lesions [ Figure 2 ]. The above findings were confirmed with fundus fluorescein angiogram and optical coherence tomography was done [ Figures 3 and 4 ]. Electro retinogram was normal. Electrooculogram (EOG), which is a diagnostic test for best disease was done for this patient and it showed reduced Arden's ratio [ Figure 5 ]. With the above clinical findings and EOG findings the patient was diagnosed to have best disease-right eye Pseudohypopyon stage and left eye vitelliruptive stage. As best disease is autosomal dominant disease and can occur in family members, his parents and siblings were called for ocular examination [ Figure 6 ]. Examination of his father was normal but mother and sister showed fundus appearance suggestive of best vitelliform disease with normal visual acuity [ Figure 7 -9].
DISCUSSION
Dr. Franz Best, a German ophthalmologist, described this type of fundus lesions in 1905. [1] Best disease, or vitelliform macular dystrophy, is a bilateral macular dystrophy with autosomal dominant inheritance characterized by the subretinal accumulation of yellowish egg yolk-like material in the macular area. [2] Mutation in VMD2 gene, which codes for a bestrophin, mapped to 11q13, have been associated CHRISMED Journal of Health and Research /Vol 1/Issue 3/ Jul-Sep 2014 and in the sub-RPE space, particularly in the foveal area, which causes atrophy of RPE and photoreceptors. [3] Visual acuity usually is normal in early stages and ophthalmoscopic findings precede visual impairment. Visual acuity deteriorates moderately. [4] Electrooculogram (EOG) is the diagnostic test for evaluating best disease. Reduced Arden's ratio (light-peak/dark-trough) (normal ratio is 1.8) even in presence of normal ERG suggests best disease. [5] Visual loss occurs in best disease due to macular scarring, choroidal neovascular membrane and geographic atrophy. [6] There is no specific treatment for best disease. Genetic counselling for best disease family members is important. [4] In developing countries, like India, many families do not come for counselling and follow-up, as so many diseases are not found. Hence, in future steps should be taken to screen family members and educate them. Counselling should be given to patients with genetic diseases and their family members before they lose their vision.
